Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
Mark A. Gregory(University of Colorado Anschutz Medical Campus), James DeGregori(University of Colorado Cancer Center), Vadym Zaberezhnyy(University of Colorado Anschutz Medical Campus), Craig T. Jordan(University of Colorado Anschutz Medical Campus), Sarah Gehrke(University of Colorado Denver), Travis Nemkov(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Hae J. Park(University of Colorado Anschutz Medical Campus), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Biniam Adane(University of Colorado Anschutz Medical Campus)
Cited by 165
Related Papers
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
|Blood|2005|675
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556